5 documents found, page 1 of 1
Magnitude and temporal variations of socioeconomic inequalities in the quality ...
Sandoval, José Luis; Franzoi, Maria Alice; Di Meglio, Antonio; Ferreira, Arlindo R.; Viansone, Alessandro; André, Fabrice; Martin, Anne LaurePURPOSE: Socioeconomic status (SES) influences the survival outcomes of patients with early breast cancer (EBC). However, limited research investigates social inequalities in their quality of life (QoL). This study examines the socioeconomic inequalities in QoL after an EBC diagnosis and their time trends. PATIENTS AND METHODS: We used data from the French prospective multicentric CANTO cohort (ClinicalTrials.g...
Implementation of a remote symptom monitoring pathway in oncology care: analysi...
Franzoi, Maria Alice; Ferreira, Arlindo R.; Lemaire, Antoine; Rodriguez, Joseph; Grosjean, Jessica; Ribeiro, Joana M.; Polastro, Laura; Grellety, ThomasBackground: Remote patient monitoring (RPM) of symptoms using electronic patient reported outcomes (ePROs) has been shown to reduce symptom burden and hospitalizations, increase dose intensity and improve quality of life of patients during systemic therapy being recommended by international guidelines in routine oncology practice. However, implementation in routine care has been slow and faces several challenge...
Correction to: Surgery of the primary tumor in patients with de novo metastatic...
Brandão, Mariana; Martins-Branco, Diogo; Angelis, Claudia De; Vuylsteke, Peter; Gelber, Richard D.; Damme, Nancy Van; Walle, Lien vanIn the original publication of the article, the following article note has been missed to include. “Mariana Brandão and Diogo Martins-Branco have contributed equally to this work.” The original article has been corrected.
Effectiveness of palbociclib with aromatase inhibitors for the treatment of adv...
Costa, Filipa Alves da; Borges, Fábio Cardoso; Ramos, Adriana; Mayer, Alexandra; Brito, Claudia; Ramos, Catarina; Bernardo, Catarina; Cossito, MarianeBackground: New drugs for locally advanced or metastatic breast cancer have led to clinical benefits, aside with increasing costs to healthcare systems. The current financing model for health technology assessment (HTA) privileges real-world data. As part of the ongoing HTA, this study aimed to evaluate the effectiveness of palbociclib with aromatase inhibitors (AI) and compare it with the efficacy reported in ...
PET/CT in patients with breast cancer treated with immunotherapy
Vaz, Sofia C.; Graff, Stephanie L.; Ferreira, Arlindo R.; Debiasi, Márcio; de Geus-Oei, Lioe FeeSignificant advances in breast cancer (BC) treatment have been made in the last decade, including the use of immunotherapy and, in particular, immune checkpoint inhibitors that have been shown to improve the survival of patients with triple negative BC. This narrative review summarizes the studies supporting the use of immunotherapy in BC. Furthermore, the usefulness of 2-deoxy-2-[18F]fluoro-D-glucose (2-[18F]F...